Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft models
10.1038/s41392-018-0010-0
Saved in:
Main Authors: | Syn N.L., Lim P.L., Kong L.R., Wang L., Wong A.L.-A., Lim C.M., Loh T.K.S., Siemeister G., Goh B.C., Hsieh W.-S. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
Springer Nature
2019
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/151596 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Cisplatin and 5-fluorouracil continuous infusion for metastatic nasopharyngeal carcinoma
by: Wang, T.L., et al.
Published: (2014) -
CDK4/6 INHIBITORS AS NOVEL THERAPY IN NASOPHARYNGEAL CARCINOMA
by: BUI NGOC LINH CHI
Published: (2021) -
Integration of antiangiogenic therapy with cisplatin and gemcitabine chemotherapy in patients with nasopharyngeal carcinoma.
by: Chong, Wan Qin, et al.
Published: (2020) -
Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers
by: Li F., et al.
Published: (2020) -
Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5
by: Kesavapany, S., et al.
Published: (2011)